Create a narrative

Allurion Technologies Community

NYSE:ALUR Community

1 Narratives written by author
0 Comments on narratives written by author
11 Fair Values set on narratives written by author

Allurion Technologies

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Expanding Obesity Solutions Will Boost Prospects Amid Launch Uncertainties

Key Takeaways Shifting to comprehensive, minimally invasive obesity solutions with device-plus-GLP-1 strategy supports stronger adoption, retention, and revenue growth opportunities worldwide. Streamlined operations and innovative product pipeline position the company for improved margins, cash flow, and long-term leadership as regulatory milestones approach.

US$8.38

FV

71.3% undervalued

-0.74%

Revenue growth p.a.

0

0

10

Updated